LARC

Postpartum etonogestrel-releasing implants and depression

June 24, 2020

Rates of depression at 6 weeks postpartum among adolescents and young adults (AYA) were significantly lower in those initiating immediate postpartum etonogestrel (ENG) implants compared to other birth control methods, according to new research.

Contraceptive use in women with cystic fibrosis

June 02, 2020

Nearly half of women of child-bearing age with cystic fibrosis use estrogen-containing oral contraceptive pills, followed by condoms and long-acting reversible contraceptive methods, according to a pilot study in the journal Contraception.

Reducing endometriosis pain with LARC

March 04, 2020

Both the etonogestrel (ENG)-releasing subdermal implant and a levonorgestrel-releasing intrauterine system (LNG-IUS) significantly reduce pain in women with endometriosis, according to new research.

Data from LARC study prompt state policy change

February 19, 2020

When long-acting reversible contraception (LARC) was offered to teenage mothers prior to hospital discharge, it drastically reduced the rate of rapid repeat pregnancy, according to a study of adolescents in Indiana.